SARS-CoV-2 and the Brain: What Do We Know about the Causality of 'Cognitive COVID?
Hashir Ali Awan,Mufaddal Najmuddin Diwan,Alifiya Aamir,Muneeza Ali,Massimo Di Giannantonio,Irfan Ullah,Sheikh Shoib,Domenico De Berardis,Domenico De Berardis +8 more
Reads0
Chats0
TLDR
In this paper, the authors highlight the current understanding of the various direct and indirect mechanisms, focusing on the role of neurotropism of SARS-CoV-2, the general pro-inflammatory state, and the pandemic-associated psychosocial stressors in the causality of cognitive COVID.Abstract:
The second year of the COVID-19 (coronavirus disease) pandemic has seen the need to identify and assess the long-term consequences of a SARS-CoV-2 infection on an individual's overall wellbeing, including adequate cognitive functioning. 'Cognitive COVID' is an informal term coined to interchangeably refer to acute changes in cognition during COVID-19 and/or cognitive sequelae with various deficits following the infection. These may manifest as altered levels of consciousness, encephalopathy-like symptoms, delirium, and loss of various memory domains. Dysexecutive syndrome is a peculiar manifestation of 'Cognitive COVID' as well. In the previous major outbreaks of viruses like SARS-CoV, MERS-CoV and Influenza. There have been attempts to understand the underlying mechanisms describing the causality of similar symptoms following SARS-CoV-2 infection. This review, therefore, is attempting to highlight the current understanding of the various direct and indirect mechanisms, focusing on the role of neurotropism of SARS-CoV-2, the general pro-inflammatory state, and the pandemic-associated psychosocial stressors in the causality of 'Cognitive COVID.' Neurotropism is associated with various mechanisms including retrograde neuronal transmission via olfactory pathway, a general hematogenous spread, and the virus using immune cells as vectors. The high amounts of inflammation caused by COVID-19, compounded with potential intubation, are associated with a deleterious effect on the cognition as well. Finally, the pandemic's unique psychosocial impact has raised alarm due to its possible effect on cognition. Furthermore, with surfacing reports of post-COVID-vaccination cognitive impairments after vaccines containing mRNA encoding for spike glycoprotein of SARS-CoV-2, we hypothesize their causality and ways to mitigate the risk. The potential impact on the quality of life of an individual and the fact that even a minor proportion of COVID-19 cases developing cognitive impairment could be a significant burden on already overwhelmed healthcare systems across the world make it vital to gather further evidence regarding the prevalence, presentation, correlations, and causality of these events and reevaluate our approach to accommodate early identification, management, and rehabilitation of patients exhibiting cognitive symptoms.read more
Citations
More filters
Journal ArticleDOI
Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice.
Min-Wen Ku,Pierre Authié,Maryline Bourgine,François Anna,Amandine Noirat,Fanny Moncoq,Benjamin Vesin,Fabien Nevo,Jodie Lopez,Philippe Souque,Catherine Blanc,Ingrid Fert,Sébastien Chardenoux,llta Lafosse,Delphine Cussigh,David Hardy,Kirill Nemirov,Françoise Guinet,Francina Langa Vives,Laleh Majlessi,Pierre Charneau +20 more
TL;DR: In this paper, a transgenic mouse strain expressing the human angiotensin-converting enzyme 2 was generated, and the brain permissiveness to SARS-CoV-2 replication was shown to be high in the lung.
Journal ArticleDOI
Imatinib inhibits SARS-CoV-2 infection by an off-target-mechanism
Romano Strobelt,Julia Adler,Nir Paran,Yfat Yahalom-Ronen,Sharon Melamed,Boaz Politi,Ziv Shulman,Dominik Schmiedel,Yosef Shaul +8 more
TL;DR: In this article , an Abl tyrosine kinase inhibitor, imatinib, was shown to robustly decrease SARS-CoV-2 infection and uncover a mechanism of action.
Journal ArticleDOI
Imatinib inhibits SARS-CoV-2 infection by an off-target-mechanism
Romano Strobelt,Julia Adler,Nir Paran,Yfat Yahalom-Ronen,Sharon Melamed,Boaz Politi,Ziv Shulman,Dominik Schmiedel,Yosef Shaul +8 more
TL;DR: In this paper , an Abl tyrosine kinase inhibitor, imatinib, was shown to robustly decrease SARS-CoV-2 infection and uncover a mechanism of action.
Journal ArticleDOI
The phenotype and prediction of long-term physical, mental and cognitive COVID-19 sequelae 20 months after recovery, a community-based cohort study in China
Yimiao Zhao,Le Shi,Zhendong Jiang,Na Zeng,Huan Mei,Yu Lu,Jinfeng Yang,Fenshu Jin,Shuyu Ni,Shuilin Wu,Sizhen Su,Yong-Bo Zheng,Kai Yuan,Wei Yan,Siwei Sun,Shi-Qiu Meng,Jie Sun,Zunera Khan,Dag Aarsland,Jie Shi,Xiangyou Li,Yanping Bao,Lin Lu +22 more
TL;DR: Wang et al. as discussed by the authors reported findings for 1000 survivors 20 months after diagnosis of COVID-19 in a community-based cohort in China, collected from a validated questionnaire covering 27 symptoms involved in five organ systems including self-reported physical condition, dyspnea, cognitive function and mental health.
Journal ArticleDOI
COVID-19 causes neuronal degeneration and reduces neurogenesis in human hippocampus
Amir-Hossein Bayat,Helia Azimi,Meysam Hassani Moghaddam,Vahid Ebrahimi,Mobina Fathi,Kimia Vakili,Gholam-Reza Mahmoudiasl,Mahdi Forouzesh,Mahdi Eskandarian Boroujeni,Zahra Nariman,Hojjat-Allah Abbaszadeh,Arefeh Aryan,Abbas Aliaghaei,Mohammad-Amin Abdollahifar +13 more
TL;DR: In this paper , the authors used histological techniques to analyze glial and neuronal cells, and illuminated a massive degeneration of neuronal cells and changes in glial cells morphology in hippocampal samples.
References
More filters
Journal ArticleDOI
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu,Jennifer M. McGoogan +1 more
TL;DR: Hospitalised COVID-19 patients are frequently elderly subjects with co-morbidities receiving polypharmacy, all of which are known risk factors for d
Journal ArticleDOI
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.
Roujian Lu,Xiang Zhao,Juan Li,Peihua Niu,Bo Yang,Honglong Wu,Wenling Wang,Hao Song,Baoying Huang,Na Zhu,Yuhai Bi,Xuejun Ma,Faxian Zhan,Liang Wang,Tao Hu,Hong Zhou,Zhenhong Hu,Weimin Zhou,Li Zhao,Jing Chen,Yao Meng,Ji Wang,Yang Lin,Jianying Yuan,Zhihao Xie,Jinmin Ma,William J. Liu,Dayan Wang,Wenbo Xu,Edward C. Holmes,George F. Gao,George F. Gao,Guizhen Wu,Weijun Chen,Weifeng Shi,Wenjie Tan,Wenjie Tan +36 more
TL;DR: The phylogenetic analysis suggests that bats might be the original host of this virus, an animal sold at the seafood market in Wuhan might represent an intermediate host facilitating the emergence of the virus in humans.
Journal ArticleDOI
An interactive web-based dashboard to track COVID-19 in real time.
TL;DR: The outbreak of the 2019 novel coronavirus disease (COVID-19) has induced a considerable degree of fear, emotional stress and anxiety among individuals around the world.
Journal ArticleDOI
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.
Daniel Wrapp,Nianshuang Wang,Kizzmekia S. Corbett,Jory A. Goldsmith,Ching-Lin Hsieh,Olubukola M. Abiona,Barney S. Graham,Jason S. McLellan +7 more
TL;DR: The authors show that this protein binds at least 10 times more tightly than the corresponding spike protein of severe acute respiratory syndrome (SARS)–CoV to their common host cell receptor, and test several published SARS-CoV RBD-specific monoclonal antibodies found that they do not have appreciable binding to 2019-nCoV S, suggesting that antibody cross-reactivity may be limited between the two RBDs.
Journal ArticleDOI
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.
Ling Mao,Huijuan Jin,Mengdie Wang,Yu Hu,Shengcai Chen,Quan-Wei He,Jiang Chang,Candong Hong,Yifan Zhou,David Z. Wang,Xiaoping Miao,Yanan Li,Bo Hu +12 more
TL;DR: During the epidemic period of COVID-19, clinicians should suspect severe acute respiratory syndrome coronavirus 2 infection as a differential diagnosis to avoid delayed diagnosis or misdiagnosis and lose the chance to treat and prevent further transmission.